|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.843
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.831
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.783
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.735
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.647
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.592
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.567
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.514
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.434
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.432
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.428
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.398
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.358
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.349
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.338
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.313
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.300
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.282
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.274
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.266
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.255
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.251
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.247
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.245
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.241
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.240
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.236
|
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.232
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.219
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.216
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.207
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.204
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.200
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.200
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.192
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.191
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.190
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.187
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.180
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.176
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.168
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.166
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.162
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.144
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.138
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.133
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.132
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.131
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.130
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.126
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.124
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.123
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.120
|
|
|
|
peptide cross linking
|
GO:0018149 |
10 |
0.112
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.111
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.108
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.107
|
|
|
|
limb bud formation
|
GO:0060174 |
10 |
0.106
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.103
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.102
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.102
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.101
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.097
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.096
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.094
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.094
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.093
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.093
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.089
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.088
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.088
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.085
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.085
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.084
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.084
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.082
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.082
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.082
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.081
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.080
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.079
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.078
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.078
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.078
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.077
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.076
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.075
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.075
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.073
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
16 |
0.070
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.068
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.068
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.067
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.066
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.066
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.065
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.065
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.064
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
16 |
0.064
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.063
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.063
|
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.062
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.062
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.062
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.061
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.060
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.060
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.059
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.059
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.058
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.058
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.057
|
|
|
|
aorta smooth muscle tissue morphogenesis
|
GO:0060414 |
2 |
0.057
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.057
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.057
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.057
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.056
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.056
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.056
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.056
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.055
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.054
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.053
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.053
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.053
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.051
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.051
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.051
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.049
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.048
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.048
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.048
|
|
|
|
positive regulation of ras protein signal transduction
|
GO:0046579 |
13 |
0.047
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.047
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.047
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.047
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.046
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.046
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.046
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.045
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.044
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.044
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.044
|
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.043
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.042
|
|
|
|
peptide cross linking via chondroitin 4 sulfate glycosaminoglycan
|
GO:0019800 |
8 |
0.042
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.042
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.042
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.042
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.041
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.040
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.040
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.039
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.039
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.039
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.038
|
|
|
|
regulation of macrophage migration inhibitory factor signaling pathway
|
GO:2000446 |
1 |
0.038
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.038
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.038
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.038
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.038
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.037
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.037
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.037
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.036
|
|
|
|
clathrin coat assembly
|
GO:0048268 |
2 |
0.036
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.035
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.035
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.035
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.035
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.034
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.034
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.033
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.032
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.032
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.032
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.032
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.031
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.031
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.031
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.031
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.031
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.031
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.030
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.030
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.030
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.030
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.030
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.029
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.029
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.029
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.029
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.028
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.028
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.028
|
|
|
|
tooth mineralization
|
GO:0034505 |
9 |
0.028
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.028
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.028
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.028
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.028
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.027
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.027
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.027
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.027
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.027
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.026
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.026
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.026
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.026
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.026
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.026
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.025
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.025
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.025
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.025
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.025
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.025
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.024
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.024
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.024
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.024
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.024
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.024
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.024
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.023
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
12 |
0.023
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.023
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
7 |
0.023
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.023
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.023
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.023
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.023
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.023
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.023
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.022
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.022
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.022
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.022
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.022
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.022
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.021
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.021
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.021
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.021
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.021
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.021
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.021
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.021
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.020
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.020
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.020
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.020
|
|
|
|
negative regulation of neuron migration
|
GO:2001223 |
6 |
0.020
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.020
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.020
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.020
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.020
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.020
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.020
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.019
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.019
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.019
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.019
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.019
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.019
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.019
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.018
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.018
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.018
|
|
|
|
negative regulation of protein localization to plasma membrane
|
GO:1903077 |
5 |
0.018
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.018
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.018
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.018
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.018
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.018
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.018
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.017
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.017
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.017
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.017
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.017
|
|
|
|
regulation of cytokine secretion involved in immune response
|
GO:0002739 |
4 |
0.017
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.017
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.017
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.017
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.016
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.016
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.016
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.016
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.016
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.016
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.016
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.016
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.016
|
Zebrafish |
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.016
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.016
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.016
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.016
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.016
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.015
|
|
|
|
neurotransmitter catabolic process
|
GO:0042135 |
3 |
0.015
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.015
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.015
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.015
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.015
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.015
|
|
|
|
cellular response to vitamin
|
GO:0071295 |
2 |
0.015
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.015
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.015
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.015
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.015
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.015
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.015
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.014
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.014
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.014
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.014
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.014
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.014
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.014
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.014
|
|
|
|
notochord cell differentiation
|
GO:0060034 |
1 |
0.014
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.014
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.014
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.014
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.014
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.014
|
|
|
|
negative regulation of cell proliferation involved in contact inhibition
|
GO:0060244 |
3 |
0.014
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.014
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.014
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.013
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.013
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.013
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.013
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.013
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.013
|
|
|
|
response to defense related host nitric oxide production
|
GO:0052565 |
2 |
0.013
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.013
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
7 |
0.013
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.013
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.013
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.013
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.013
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.012
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.012
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.012
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.012
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.012
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.012
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.012
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.012
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
|
positive regulation of hormone metabolic process
|
GO:0032352 |
3 |
0.012
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.012
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.012
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.012
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.012
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.012
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.012
|
|
|
|
negative regulation of lipase activity
|
GO:0060192 |
7 |
0.012
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.012
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.012
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.012
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.012
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.012
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.012
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.012
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.012
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.011
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.011
|
|
|
|
negative regulation of embryonic development
|
GO:0045992 |
22 |
0.011
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.011
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.011
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.011
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.011
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.011
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.011
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.011
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.011
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.011
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.011
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.011
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.011
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.011
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.011
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.011
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.011
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.011
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.011
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.011
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.011
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.011
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.011
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.011
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.011
|
|
|
|
endodermal cell differentiation
|
GO:0035987 |
14 |
0.011
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.011
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.011
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.011
|
|
|
|
otic vesicle development
|
GO:0071599 |
14 |
0.011
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.011
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.010
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.010
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.010
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.010
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.010
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.010
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.010
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.010
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.010
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.010
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
2 |
0.010
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.010
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.010
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.010
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.010
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.010
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.010
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.010
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.010
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.010
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.010
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.010
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.010
|
|
|
|
otolith morphogenesis
|
GO:0032474 |
3 |
0.010
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.010
|
|